BPC-157 vs GHK-Cu
Updated 8 sources
Key differences
- 1BPC-157 targets deep tissue such as tendons and the gut. GHK-Cu targets skin and collagen.
- 2GHK-Cu targets skin, collagen and remodeling. BPC-157 targets tendons, the gut and deep tissue.
Side by side
Facts from each record, in the same words as their own pages.
| BPC-157 | GHK-Cu | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms |
|
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
8 sources, each checked by date. Record updated Oct 23, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study1
- He L et al. 2022, pharmacokinetics of BPC-157 in rats and dogs, Front PharmacolPubMed · checked Oct 23, 2026
Regulatory2
- FDA to remove 12 peptides from Category 2Frier Levitt · checked Oct 23, 2026
- An FDA committee just voted in favor of peptidesTIME, via a news report · checked Oct 23, 2026
Vendor guide1
- GHK-Cu beyond cosmetic hype (pharmacist review, 2026-02-11)Fagron Academy · checked Oct 23, 2026
Competitor guide4
- BPC-157 profilepathtopeptides.com · checked Oct 23, 2026
- BPC-157 vs GHK-Cupathtopeptides.com · checked Oct 23, 2026
- BPC-157peptidesinsider.com · checked Oct 23, 2026
- GHK-Cu half-life and shelf lifepeptidedeck.com · checked Oct 23, 2026